Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Piersimoni

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Clinical Microbiology|October 27, 2012
Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculumClaudio Piersimoni, Alessandro Mustazzolu, Federico Giannoni, et al.
Emerging Infectious Diseases|October 27, 2004
Mycobacterium triplex pulmonary disease in immunocompetent hostClaudio Piersimoni, Piergiorgio Zitti, Gianna Mazzarelli, et al.
Journal of Clinical Microbiology|August 7, 2004
Mycobacterium lentiflavum as an emerging causative agent of cervical lymphadenitisClaudio Piersimoni, Gaia Goteri, Domenico Nista, et al.
Annali Dell'Istituto Superiore Di Sanita|April 11, 2019
Revisiting problems and solutions to decrease Mycobacterium tuberculosis pyrazinamide false resistance when using the Bactec MGIT 960 systemAlessandro Mustazzolu, Claudio Piersimoni, Angelo Iacobino, et al.
Diagnostic Microbiology and Infectious Disease|October 27, 2005
Clinical suspicion as a primary guidance to use commercial amplification tests for rapid diagnosis of pulmonary tuberculosisClaudio Piersimoni, Domenico Nista, Diego Zallocco, et al.
Journal of Clinical Microbiology|November 1, 2002
Performance assessment of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex from respiratory and extrapulmonary specimensClaudio Piersimoni, Claudio Scarparo, Paola Piccoli, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
New N-alkyl-1,2-dihydro-2-thioxo-3-pyridinecarbothioamides as antituberculous agents with improved pharmacokineticsDaniela Ubiali, Giuseppe Pagani, Massimo Pregnolato, et al.
Journal of Clinical Microbiology|July 8, 2005
Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patientFrancesca Meacci, Germano Orrù, Elisabetta Iona, et al.
Diagnostic Microbiology and Infectious Disease|March 7, 2007
Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacinClaudio Piersimoni, Carla Lacchini, Valeria Penati, et al.
Emerging Infectious Diseases|March 12, 2011
Tuberculosis in kindergarten and primary school, Italy, 2008-2009Antonietta Filia, Giuseppe Ciarrocchi, Rossana Belfiglio, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Clinical Microbiology|October 27, 2012
Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculumClaudio Piersimoni, Alessandro Mustazzolu, Federico Giannoni, et al.
Emerging Infectious Diseases|October 27, 2004
Mycobacterium triplex pulmonary disease in immunocompetent hostClaudio Piersimoni, Piergiorgio Zitti, Gianna Mazzarelli, et al.
Journal of Clinical Microbiology|August 7, 2004
Mycobacterium lentiflavum as an emerging causative agent of cervical lymphadenitisClaudio Piersimoni, Gaia Goteri, Domenico Nista, et al.
Annali Dell'Istituto Superiore Di Sanita|April 11, 2019
Revisiting problems and solutions to decrease Mycobacterium tuberculosis pyrazinamide false resistance when using the Bactec MGIT 960 systemAlessandro Mustazzolu, Claudio Piersimoni, Angelo Iacobino, et al.
Diagnostic Microbiology and Infectious Disease|October 27, 2005
Clinical suspicion as a primary guidance to use commercial amplification tests for rapid diagnosis of pulmonary tuberculosisClaudio Piersimoni, Domenico Nista, Diego Zallocco, et al.
Journal of Clinical Microbiology|November 1, 2002
Performance assessment of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex from respiratory and extrapulmonary specimensClaudio Piersimoni, Claudio Scarparo, Paola Piccoli, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
New N-alkyl-1,2-dihydro-2-thioxo-3-pyridinecarbothioamides as antituberculous agents with improved pharmacokineticsDaniela Ubiali, Giuseppe Pagani, Massimo Pregnolato, et al.
Journal of Clinical Microbiology|July 8, 2005
Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patientFrancesca Meacci, Germano Orrù, Elisabetta Iona, et al.
Diagnostic Microbiology and Infectious Disease|March 7, 2007
Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacinClaudio Piersimoni, Carla Lacchini, Valeria Penati, et al.
Emerging Infectious Diseases|March 12, 2011
Tuberculosis in kindergarten and primary school, Italy, 2008-2009Antonietta Filia, Giuseppe Ciarrocchi, Rossana Belfiglio, et al.
Pageof 3